http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106317194-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
filingDate 2015-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106317194-B
titleOfInvention Ring histidyl--KARPAK, synthesis, thrombus related activity and application
abstract The invention discloses following formula ring histidyl--KARPAK (6s) -4,5,6,7- tetrahydro -3H- imidazoles [4,5-c] and pyridine -6- formyl-Lys-Ala-Arg-Pro-Ala-Lys, its preparation method is disclosed, the effect that it treats rats with stroke is disclosed, thus the invention discloses it, and the application treated in hemorrhagic apoplexy drug is lacked in preparation.
priorityDate 2015-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103665107-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102796167-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451010199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21866389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416172369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420230559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7016106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11228693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415859033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56972736
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135399369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425153719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9964828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21583954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426382996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422576883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426128830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426174133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9227

Total number of triples: 58.